Cantor Fitzgerald Weighs in on ACRS FY2025 Earnings
Aclaris Therapeutics, Inc. (NASDAQ:ACRS – Free Report) – Equities researchers at Cantor Fitzgerald issued their FY2025 earnings per share estimates for shares of Aclaris Therapeutics in a research note issued to investors on Tuesday, March 4th. Cantor Fitzgerald analyst P. Agrawal expects that the biotechnology company will post earnings of ($0.54) per share for the […]
Aclaris Therapeutics, Inc. (NASDAQ:ACRS – Free Report) – Equities researchers at Cantor Fitzgerald issued their FY2025 earnings per share estimates for shares of Aclaris Therapeutics in a research note issued to investors on Tuesday, March 4th. Cantor Fitzgerald analyst P. Agrawal expects that the biotechnology company will post earnings of ($0.54) per share for the […]
